Low-dose BPC-157 (150-250mcg daily) with occasional TB-500 (2mg monthly) provides ongoing healing support without intensive resource use
Clinical Data Phase 2 clinical studies of cagrilintide monotherapy in adults with obesity reported dose-dependent weight reductions of 6.0% to 10.8% over 26 weeks with a favourable tolerability profile
Xiang et al., 2020), resveratrol (Yu et al., 2017
Does Enclomiphene Make You Stronger
Peanut allergy peptide therapy One of the most exciting developments is PVX108, a peptide therapy being developed for peanut allergies
Levels of Glutathione decline with age and of all the nutrients that display antioxidant activity, Glutathione is the most powerful donor of electrons, which help neutralise free radicals, helping to prevent oxidative stress